JONATHON MCCRARY: Open Payments
NPI 1851764856 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 19 payments from 10 companies in 2025. Trend: 2023 $523 · 2024 $944 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $48 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $8 |
Products named: Kerendia, Wegovy, LifeVest, ZEPBOUND, REPATHA, ONPATTRO, INJECTAFER, VERQUVO.
Industry payments across OK — which companies pay providers there.
